MDS And AML Patients May Achieve Similar Outcomes Post Transplant With ... The MDS Beacon In addition, 95 percent of patients received fludarabine (Fludara). For the prevention of GVHD, 79 percent of patients received cyclosporine (Sandimmune) plus mycophenolate mofetil (Cellcept). Anti-thymocyte globulin (ATG) was given to 53 percent of ... |
